Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation

A plethora of functional and genetic studies have suggested a key role for the IL-23 pathway in chronic intestinal inflammation. Currently, pathogenic actions of IL-23 have been ascribed to specific effects on immune cells. Herein, we unveil a protective role of IL-23R signaling. Mice deficient in I...

Full description

Bibliographic Details
Main Authors: Konrad Aden, Ateequr Rehman, Maren Falk-Paulsen, Thomas Secher, Jan Kuiper, Florian Tran, Steffen Pfeuffer, Raheleh Sheibani-Tezerji, Alexandra Breuer, Anne Luzius, Marlene Jentzsch, Robert Häsler, Susanne Billmann-Born, Olga Will, Simone Lipinski, Richa Bharti, Timon Adolph, Juan L. Iovanna, Sarah L. Kempster, Richard S. Blumberg, Stefan Schreiber, Burkhard Becher, Mathias Chamaillard, Arthur Kaser, Philip Rosenstiel
Format: Article
Language:English
Published: Elsevier 2016-08-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124716309858
id doaj-c7ad691214884543bd2eb9b5ed88874d
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Konrad Aden
Ateequr Rehman
Maren Falk-Paulsen
Thomas Secher
Jan Kuiper
Florian Tran
Steffen Pfeuffer
Raheleh Sheibani-Tezerji
Alexandra Breuer
Anne Luzius
Marlene Jentzsch
Robert Häsler
Susanne Billmann-Born
Olga Will
Simone Lipinski
Richa Bharti
Timon Adolph
Juan L. Iovanna
Sarah L. Kempster
Richard S. Blumberg
Stefan Schreiber
Burkhard Becher
Mathias Chamaillard
Arthur Kaser
Philip Rosenstiel
spellingShingle Konrad Aden
Ateequr Rehman
Maren Falk-Paulsen
Thomas Secher
Jan Kuiper
Florian Tran
Steffen Pfeuffer
Raheleh Sheibani-Tezerji
Alexandra Breuer
Anne Luzius
Marlene Jentzsch
Robert Häsler
Susanne Billmann-Born
Olga Will
Simone Lipinski
Richa Bharti
Timon Adolph
Juan L. Iovanna
Sarah L. Kempster
Richard S. Blumberg
Stefan Schreiber
Burkhard Becher
Mathias Chamaillard
Arthur Kaser
Philip Rosenstiel
Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation
Cell Reports
author_facet Konrad Aden
Ateequr Rehman
Maren Falk-Paulsen
Thomas Secher
Jan Kuiper
Florian Tran
Steffen Pfeuffer
Raheleh Sheibani-Tezerji
Alexandra Breuer
Anne Luzius
Marlene Jentzsch
Robert Häsler
Susanne Billmann-Born
Olga Will
Simone Lipinski
Richa Bharti
Timon Adolph
Juan L. Iovanna
Sarah L. Kempster
Richard S. Blumberg
Stefan Schreiber
Burkhard Becher
Mathias Chamaillard
Arthur Kaser
Philip Rosenstiel
author_sort Konrad Aden
title Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation
title_short Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation
title_full Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation
title_fullStr Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation
title_full_unstemmed Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation
title_sort epithelial il-23r signaling licenses protective il-22 responses in intestinal inflammation
publisher Elsevier
series Cell Reports
issn 2211-1247
publishDate 2016-08-01
description A plethora of functional and genetic studies have suggested a key role for the IL-23 pathway in chronic intestinal inflammation. Currently, pathogenic actions of IL-23 have been ascribed to specific effects on immune cells. Herein, we unveil a protective role of IL-23R signaling. Mice deficient in IL-23R expression in intestinal epithelial cells (Il23RΔIEC) have reduced Reg3b expression, show a disturbed colonic microflora with an expansion of flagellated bacteria, and succumb to DSS colitis. Surprisingly, Il23RΔIEC mice show impaired mucosal IL-22 induction in response to IL-23. αThy-1 treatment significantly deteriorates colitis in Il23RΔIEC animals, which can be rescued by IL-22 application. Importantly, exogenous Reg3b administration rescues DSS-treated Il23RΔIEC mice by recruiting neutrophils as IL-22-producing cells, thereby restoring mucosal IL-22 levels. The study identifies a critical barrier-protective immune pathway that originates from, and is orchestrated by, IL-23R signaling in intestinal epithelial cells.
url http://www.sciencedirect.com/science/article/pii/S2211124716309858
work_keys_str_mv AT konradaden epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT ateequrrehman epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT marenfalkpaulsen epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT thomassecher epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT jankuiper epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT floriantran epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT steffenpfeuffer epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT rahelehsheibanitezerji epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT alexandrabreuer epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT anneluzius epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT marlenejentzsch epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT roberthasler epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT susannebillmannborn epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT olgawill epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT simonelipinski epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT richabharti epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT timonadolph epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT juanliovanna epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT sarahlkempster epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT richardsblumberg epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT stefanschreiber epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT burkhardbecher epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT mathiaschamaillard epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT arthurkaser epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
AT philiprosenstiel epithelialil23rsignalinglicensesprotectiveil22responsesinintestinalinflammation
_version_ 1725101624427282432
spelling doaj-c7ad691214884543bd2eb9b5ed88874d2020-11-25T01:28:27ZengElsevierCell Reports2211-12472016-08-011682208221810.1016/j.celrep.2016.07.054Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal InflammationKonrad Aden0Ateequr Rehman1Maren Falk-Paulsen2Thomas Secher3Jan Kuiper4Florian Tran5Steffen Pfeuffer6Raheleh Sheibani-Tezerji7Alexandra Breuer8Anne Luzius9Marlene Jentzsch10Robert Häsler11Susanne Billmann-Born12Olga Will13Simone Lipinski14Richa Bharti15Timon Adolph16Juan L. Iovanna17Sarah L. Kempster18Richard S. Blumberg19Stefan Schreiber20Burkhard Becher21Mathias Chamaillard22Arthur Kaser23Philip Rosenstiel24Institute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyUniversity Toulouse, CNRS, Inserm, CHU Toulouse, UMR 1043-UMR 5282, Centre de Physiopathologie Toulouse Purpan, 31024 Toulouse, FranceInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyDivision of Gastroenterology and Hepatology, Department of Medicine, Addenbrooke’s Hospital, University of Cambridge, Cambridge CB2 0QQ, England, UKAix-Marseille University, Institut Paoli-Calmettes, CNRS, Inserm, UMR 1068-UMR 7258, Centre de Recherche en Carcérologie de Marseille, 13273 Marseille, FranceDivision of Gastroenterology and Hepatology, Department of Medicine, Addenbrooke’s Hospital, University of Cambridge, Cambridge CB2 0QQ, England, UKGastroenterology Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USAInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyInstitute of Experimental Immunology, University of Zurich, 8057 Zurich, SwitzerlandUniversity Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204–CIIL, Centre d’Infection et d’Immunité de Lille, 59000 Lille, FranceDivision of Gastroenterology and Hepatology, Department of Medicine, Addenbrooke’s Hospital, University of Cambridge, Cambridge CB2 0QQ, England, UKInstitute of Clinical Molecular Biology, Christian Albrechts University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, GermanyA plethora of functional and genetic studies have suggested a key role for the IL-23 pathway in chronic intestinal inflammation. Currently, pathogenic actions of IL-23 have been ascribed to specific effects on immune cells. Herein, we unveil a protective role of IL-23R signaling. Mice deficient in IL-23R expression in intestinal epithelial cells (Il23RΔIEC) have reduced Reg3b expression, show a disturbed colonic microflora with an expansion of flagellated bacteria, and succumb to DSS colitis. Surprisingly, Il23RΔIEC mice show impaired mucosal IL-22 induction in response to IL-23. αThy-1 treatment significantly deteriorates colitis in Il23RΔIEC animals, which can be rescued by IL-22 application. Importantly, exogenous Reg3b administration rescues DSS-treated Il23RΔIEC mice by recruiting neutrophils as IL-22-producing cells, thereby restoring mucosal IL-22 levels. The study identifies a critical barrier-protective immune pathway that originates from, and is orchestrated by, IL-23R signaling in intestinal epithelial cells.http://www.sciencedirect.com/science/article/pii/S2211124716309858